Outpatient treatment with lisocabtagene maraleucel in 3 clinical studies of relapsed/refractory large B-cell NHL, including second-line transplant noneligible patients: Transcend NHL 001, Outreach, and PILOT Meeting Abstract


Authors: Bachier, C.; Palomba, M. L.; Abramson, J.; Andreadis, C.; Sehgal, A.; Godwin, J.; Hildebrandt, G.; Siddiqi, T.; Stevens, D.; Farazi, T.; Kostic, A.; Trede, N.; Wang, L.; Lymp, J.; Thelen, T.; Ogasawara, K.; Maloney, D.
Abstract Title: Outpatient treatment with lisocabtagene maraleucel in 3 clinical studies of relapsed/refractory large B-cell NHL, including second-line transplant noneligible patients: Transcend NHL 001, Outreach, and PILOT
Meeting Title: 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Journal Title: Bone Marrow Transplantation
Volume: 55
Issue: Suppl. 1
Meeting Dates: 2020 Aug 29-Sept 1
Meeting Location: Virtual
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2020-12-11
Start Page: 47
End Page: 48
Language: English
ACCESSION: WOS:000600556200038
PROVIDER: wos
PMCID: PMC7729707
PUBMED: 33311610
DOI: 10.1038/s41409-020-01119-3
Notes: Meeting Abstract: O037 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba